Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
Joel Simrén(University of Gothenburg), Nicholas J. Ashton(King's College London), Shilla Khalil(Sahlgrenska University Hospital), Wagner S. Brum(Universidade Federal do Rio Grande do Sul), Andréa Lessa Benedet(University of Pittsburgh), Henrik Zetterberg(University of Wisconsin–Madison), Haley Weninger(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 81
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k